Patent details
EP1513519 Title: THE USE OF SUBSTITUTED CYANOPYRROLIDINES FOR TREATING HYPERLIPIDEMIA
Basic Information
- Publication number:
- EP1513519
- PCT Application Number:
- PCT/EP/2003/005762
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP037379849
- PCT Publication Number:
- WO/2003/101448
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- THE USE OF SUBSTITUTED CYANOPYRROLIDINES FOR TREATING HYPERLIPIDEMIA
- French Title of Invention:
- UTILISATION DE CYANOPYRROLIDINES SUBSTITUEES DANS LE TRAITEMENT D'HYPERLIPIDEMIE
- German Title of Invention:
- VERWENDUNG VON SUBSTITUIERTEN CYANOPYRROLIDINEN ZUR BEHANDLUNG VON HYPERLIPIDÄMIE
- SPC Number:
Dates
- Filing date:
- 02/06/2003
- Grant date:
- 18/02/2009
- EP Publication Date:
- 18/02/2009
- PCT Publication Date:
- 11/12/2003
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/03/2005
- EP B1 Publication Date:
- 18/02/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/06/2014
- Expiration date:
- 02/06/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/06/2003
- Name:
- NOVARTIS AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- HOLMES David, Grenville
- Address:
- Switzerland (CH)
2
- Name:
- HUGHES Thomas, Edward
- Address:
- United States (US)
Priority
- Priority Number:
- 385220 P
- Priority Date:
- 03/06/2002
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/40;
| Filing date | Document type | Number of pages |
|---|